Loading clinical trials...
Loading clinical trials...
A Phase 3, Prospective, Multi-Center, Single-Arm, Open-Label Study to Evaluate VeraCept®, a Long-Acting Reversible Intrauterine Contraceptive for Contraceptive Efficacy, Safety, and Tolerability
Conditions
Interventions
VeraCept
Locations
41
United States
MomDoc Women's Health Research
Scottsdale, Arizona, United States
Copperstate OB/GYN Associates
Tucson, Arizona, United States
Essential Access Health
Berkeley, California, United States
Essential Access Health
Los Angeles, California, United States
Empire Clinical Research
Pomona, California, United States
University of California, Davis Health System
Sacramento, California, United States
Start Date
August 22, 2018
Primary Completion Date
September 22, 2022
Completion Date
September 22, 2027
Last Updated
August 22, 2025
Lead Sponsor
Sebela Women's Health Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions